Reuters Market Eye - Cipla falls 2.39 pct after July-Sept earnings. The drugmaker's Q2 profit fell 16 pct to 2.99 billion rupees ($48.6 million) on sluggish exports.
Export sales in the quarter fell by 4.6 percent, according to company presentation.
Exports mainly hit by higher captive consumption of raw materials, more focus on integration into new markets - Analysts
($1 = 61.5900 rupees)
(Reporting by Abhishek Vishnoi)